| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 27/12/2024 | 22:21 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under the Securities Act of 1933 | AMEX:SCPX | Scorpius Holdings Inc |
| 27/12/2024 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:SCPX | Scorpius Holdings Inc |
| 23/12/2024 | 22:15 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] | AMEX:SCPX | Scorpius Holdings Inc |
| 23/12/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | AMEX:SCPX | Scorpius Holdings Inc |
| 11/12/2024 | 22:05 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities | AMEX:SCPX | Scorpius Holdings Inc |
| 09/12/2024 | 23:26 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | AMEX:SCPX | Scorpius Holdings Inc |
| 19/11/2024 | 13:30 | GlobeNewswire Inc. | Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model | AMEX:SCPX | Scorpius Holdings Inc |
| 14/11/2024 | 22:19 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:SCPX | Scorpius Holdings Inc |
| 14/11/2024 | 22:15 | GlobeNewswire Inc. | Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability | AMEX:SCPX | Scorpius Holdings Inc |
| 04/11/2024 | 13:30 | GlobeNewswire Inc. | Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement | AMEX:SCPX | Scorpius Holdings Inc |
| 31/10/2024 | 12:30 | GlobeNewswire Inc. | Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually | AMEX:SCPX | Scorpius Holdings Inc |
| 22/10/2024 | 14:00 | GlobeNewswire Inc. | Scorpius Holdings Announces Partnership with U.S. Biotech Company | AMEX:SCPX | Scorpius Holdings Inc |
| 02/10/2024 | 14:00 | GlobeNewswire Inc. | Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats | AMEX:SCPX | Scorpius Holdings Inc |
| 30/09/2024 | 14:00 | GlobeNewswire Inc. | Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities | AMEX:SCPX | Scorpius Holdings Inc |
| 26/09/2024 | 22:05 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | AMEX:SCPX | Scorpius Holdings Inc |
| 12/09/2024 | 14:00 | GlobeNewswire Inc. | Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE Act | AMEX:SCPX | Scorpius Holdings Inc |
| 09/09/2024 | 14:30 | GlobeNewswire Inc. | Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA | AMEX:SCPX | Scorpius Holdings Inc |
| 26/08/2024 | 14:00 | GlobeNewswire Inc. | Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow | AMEX:SCPX | Scorpius Holdings Inc |
| 20/08/2024 | 15:15 | GlobeNewswire Inc. | Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024 | AMEX:SCPX | Scorpius Holdings Inc |
| 19/08/2024 | 19:08 | GlobeNewswire Inc. | Scorpius Holdings, Inc. Announces Closing of Public Offering | AMEX:SCPX | Scorpius Holdings Inc |
| 16/08/2024 | 22:41 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] | AMEX:SCPX | Scorpius Holdings Inc |
| 16/08/2024 | 15:50 | GlobeNewswire Inc. | Scorpius Holdings, Inc. Announces Pricing of Public Offering | AMEX:SCPX | Scorpius Holdings Inc |
| 15/08/2024 | 22:00 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | AMEX:SCPX | Scorpius Holdings Inc |
| 09/08/2024 | 21:38 | GlobeNewswire Inc. | Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering | AMEX:SCPX | Scorpius Holdings Inc |
| 30/07/2024 | 14:00 | GlobeNewswire Inc. | Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to Resume Normal Trading on August 2, 2024 | AMEX:SCPX | Scorpius Holdings Inc |
| 24/07/2024 | 14:30 | GlobeNewswire Inc. | Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter | AMEX:SCPX | Scorpius Holdings Inc |
| 18/07/2024 | 14:30 | GlobeNewswire Inc. | Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility | AMEX:SCPX | Scorpius Holdings Inc |
| 17/07/2024 | 22:30 | GlobeNewswire Inc. | Scorpius Holdings Announces Reverse Stock Split | AMEX:SCPX | Scorpius Holdings Inc |
| 17/06/2024 | 23:24 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | AMEX:SCPX | Scorpius Holdings Inc |
| 17/06/2024 | 23:22 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | AMEX:SCPX | Scorpius Holdings Inc |